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The lipoate acetyltransferase (E2,Mr 70 000) and protein X (Mr 51 000) subunits of the bovine pyruvate dehydrogenase 
multienzyme complex (PDC) core assembly are antigenically distinct polypeptides. However comparison ofthe N-ter- 
minal amino acid sequence of the E2 and X polypeptides reveals ignificant homology between the two components. 
Selective tryptic release of the 14C-labelled acetylated lipoyl domains of E2 and protein X from native PDC generates 
stable, radiolabelled 34and 15 kDa fragments, respectively. Thus, in contrast to E2 which contains two tandemly-ar- 
ranged lipoyl domains, protein X appears to contain only a single lipoyl domain located at its N-terminus. 
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1. INTRODUCTION 
Mammalian pyruvate dehydrogenase complex 
(PDC), which catalyses the oxidative decarboxyla- 
tion of  pyruvate, with the formation of acetyl CoA 
and NADH,  is a high Mr assembly of 3 separate n- 
zymes acting in concert. In the native complex, 
20-30 ce2B2 tetramers of pyruvate dehydrogenase, 
E1 (EC 1.2.4.1) and 6 homodimers of 
dihydrolipoamide dehydrogenase, E3 (EC 1.8.1.4) 
are attached non-covalently to a multimeric ore 
assembly of 60 lipoic acid-containing acetyl- 
transferase (E2) subunits (EC 2.3.1.12), organised 
in the form of a pentagonal dodecahedron [1,2]. 
Attention has also focused on a minor core species, 
protein or component X [3,4], a distinct lipoyl- 
bearing polypeptide [5] which is tightly-bound to 
E2 and also participates in the acetylation reac- 
tions of the complex [6]. 
Recent cloning and sequence analysis of the 
human lipoate acetyltransferase (E2) gene [7,8] in 
conjunction with earlier protein-chemical studies 
[9] have demonstrated the presence of two 
tandemly-repeated lipoyl domains of approximate- 
ly 125 amino acids in length, located at the N- 
terminus of the polypeptide. A short, highly con- 
served E3 binding sequence is found distal to the 
second lipoyl domain followed by the C-terminal 
intersubunit binding domain which also houses the 
acetyltransferase activity. This general structure 
for E2 was first elucidated for PDC from E. coli 
[10,11] which, however, contains 3 homologous 
lipoyl domains while the equivalent S. cerevisiae 
enzyme has only a single lipoyl domain [12]. This 
paper presents evidence that protein X is also a 
functional variant or isoenzyme of E2 containing a
single lipoyl domain. 
2. MATERIALS AND METHODS 
Correspondence address: J.G. Lindsay, Department of 
Biochemistry, University of Glasgow, Glasgow G12 8QQ, 
Scotland 
PDC was purified according to the method of Stanley and 
Perham [13] with minor modifications [14]. Buffalo rat liver 
(BRL), bovine kidney (NBL-1) and porcine kidney (PK-15) cells 
were purchased from Flow Laboratories, Irvine, Scotland. 
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Subunit-specific antisera to gel-purified E2 and X subunits were 
prepared as described previously [3]. [3-14C]Pyruvate 
(17.4 mCi/mmol) was obtained from New England Nuclear 
and [~2~I]NaI (essentially carrier free) from Amersham. Protein 
A and trypsin (N-tosyl-L-phenylalanine chloromethyl ketone- 
treated) were from Sigma. Nitrocellulose (0.45/Lm pore size) 
was the product of Schlelcher and Schull, Dassel, FRG. 
Protocols for routine maintenance of mammalian cell 
cultures, preparation of cellular and mitochondrial extracts, 
standard SDS-polyacrylamide gel electrophoresis, immune 
replica analysis and detection of immune complexes with 1251- 
labelled protein A have been described [3,14,15]. 14C-labelled 
peptides were detected by fluorography following the method 
of Chamberlain [16]. 
For N-terminal sequencing of E2 and X subunits, purified 
bovine heart PDC was resolved by SDS-polyacrylamide g l elec- 
trophoresis on a 'Mighty Small II' gel apparatus (Hoefer, San 
Francisco) according to the conditions described in Applied 
Biosystems User Bulletin no.25. The gel was then blotted onto 
Immobilon membrane (Millipore, Harrow, Middlesex) as 
described by Matsudaira [17]. Protein bands were carefully ex- 
cised with a scalpel and placed in the cartridge block of an Ap- 
plied Biosystems model 470A protein sequencer equipped with 
a 120A on-line PTH analyser, using the standard O3R PTH 
programme. 
3. RESULTS 
The monospecificity and high-titre of antiserum 
raised to the gel-purified lipoate acetyltransferase 
(E2) subunit of bovine heart PDC is demonstrated 
in fig. 1 where immune replica analysis (panel A) is 
conducted against purified PDC and several 
cellular and mitochondrial extracts. Variations in 
the Mr values of the E2 subunit are evident in dif- 
ferent cell lines. In particular, the E2 polypeptide 
in BRL cells (lanes 2-4) has a lower apparent Mr 
value of 68000 compared to 70000-72000 in 
bovine and porcine tissues. This finding is in agree- 
ment with the subunit molecular masses reported 
for lipoate acetyltransferase in purified rat liver 
[18] and bovine heart PDC [3]. No cross-reaction 
of this anti-serum with the protein X polypeptide 
was observed in any cell line. 
In fig. 1 (panel B) the reactivity of anti-X serum 
is illustrated against bovine heart PDC (lane 1) and 
whole cell (lane 2), mitochondrial (lane 5), post- 
nuclear supernatant (lanes 3 and 4) and nuclear 
fractions (lane 6) derived from BRL ceils. It is evi- 
dent that the antibody to component X shows a 
strong positive cross-reaction with an unidentified 
48 kDa species which is not present in either 
nuclear or mitochondrial fractions. Its exact sub- 
cellular location has not yet been determined. In
mitochondrial extracts, however, this antibody 
reacts exclusively with a 51 kDa component cor- 
responding to protein X. Once again, anti-X IgG 
failed to recognise the E2 component in these cell 
cultures. 
In fig.2 (panel A) pure bovine heart PDC, pre- 
incubated with [3-t4C]pyruvate in the absence of 
CoA to promote [14C]acetylation f lipoyl groups 
on the proteolytically-sensitive E2 and X subunits, 
was then subjected to tryptic digestion for the in- 
dicated times to promote selective release of the 
14C-labelled lipoyl domains. Specific proteolysis of 
the [14C]acetylated domains is observed with pro- 
tein X degrading rapidly to produce a unique, 
stable, radiolabelled 15 kDa peptide (panel A), as 
confirmed by immune replica analysis (panel C). 
In contrast, E2 is cleaved more slowly via a tran- 
sient 14C-labelled 45 kDa species, finally 
generating a stable 34 kDa lipoyl peptide (panel 
A). Verification that these polypeptides were tryp- 
tic fragments of E2 and X, respectively, was again 
achieved by immunoblotting with subunit-specific 
antisera (panel B). A similar pattern of E2 and X- 
derived cleavage products could be obtained with 
several specific (e.g. V-8 protease) or non-specific 
(e.g. papain, elastase) proteases (not shown). 
Table 1 compares the N-terminal amino acid se- 
quences of the bovine heart E2 and protein X 
polypeptides with the equivalent primary struc- 
tures of the human [7,8], rat [19] and S. cerevisiae 
[12] lipoate acetyltransferases d rived from deter- 
mination of the nucleotide sequences of the cloned 
genes. Protein X exhibits significant homology 
with all eukaryotic lipoate acetyltransferases ex- 
amined to date, particularly evidenced in a highly 
conserved PS/ALSPTM sequence commencing at
residues 9-12 from the N-terminus or at equivalent 
positions in the internally repeated lipoyl domains 
of the human and rat enzymes. There are two other 
positions in which complete identity is retained in 
all cases involving an invariant proline near the N- 
terminus and a glycine located in the C-terminal 
region of this peptide sequence. Interestingly, a 
conserved histidine at position 3 or 4, present in all 
these lipoate acetyltransferases including the yeast 
enzyme, isabsent in protein X, as is a conserved N- 
terminal serine (residue 1 or 2). 
The corresponding stretches of amino acid se- 
quence from the N-terminal and internally 
repeated lipoyl domains of human E2 reveal se- 
quence identity in 15 out of 24 residues while pro- 
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Fig. 1. Immunoblotting analysis of lipoate acetyltransferase (E2) and protein X in various cellular extracts. Purified PDC and various 
cellular extracts were resolved by electrophoresis on 10% (w/v) SDS-polyacrylamide gels. Gels were used for immunoblotting analysis 
(see section 2 for details) with antibody raised against he E2 subunit (panel A) or protein X subunit (panel B). (A) Lanes: 1 and 5, 
0.1/~g PDC; 2, SDS extract of BRL cells, 80/zg; 3, BRL mitochondria, 40/~g; 4, rat liver mitochondria, 40/~g; 6, ox heart 
mitochondria, 15/~g; 7, SDS extract of NBL-1 cells, 80/zg; 8, SDS extract of PK-15 cells, 80/zg; 9, PK-15 mitochondria, 20/zg; 10, 
PK-15 post-mitochondrial supernate, 60/~g; S, 125I-labelled molecular mass marker, bovine serum albumin. (B) Lanes: 1, 0.5/zg 
purified PDC; 2, SDS extract of BRL cells; 3 and 4, post-nuclear supernate, 50 and 60/zg; 5, BRL mitochondria, 40/~g; 6, nuclear 
fraction, 40/~g; S, ~2~I-labelled molecular mass markers. 
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Fig.2. Selective tryptic release of [14C]acetylated lipoyl domains from E2 and X polypeptides of native bovine heart PDC. Purified 
bovine heart PDC (500 #g) was preincubated for 15 rain with non-radioactive (panels B and C) or [3-14C]pyruvate (panel A) in the 
presence of 0.5 mM N-ethylmaleimide. Excess N-ethylmaleimide was reacted with 45 mM 2-mercaptoethanol before treatment of 
radiolabelled enzyme with 1 °70 (w/w) trypsin at 25°C for the indicated times. Samples (30 pg) were removed, immediately treated with 
Laemmli sample buffer (2 x ) and subjected to fluorography following resolution on 12.5°70 (w/v) SDS-polyacrylamide gels (panel A) 
[14C]acetylated peptides; panels (B&C) immunoblots of parallel samples with anti-E2 and anti-X sera, respectively. 
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Table 1 
Comparison of N-terminal amino acid sequences of protein X 
and various lipoate acetyltransferases (E2) from eukaryotic 
sources  
E2  
Bov ine  hear t  A D P I - - K l L 
p rote in  X 
Human l iver  
E2  (b] ' P P M Q v L 
V M V Rat  l iver 1191 P Q I 
E2  {b) 
S .cerev ls iae I l2}  A Y P E T I I G 
E2  
L S L S P T MQA~TT I A - 
M S L S P /oT  M E E IG]  N I (VI(K) 
S L S P T MQAIG IT  I A R 
A L S P T MT MIG[T  V Q R 
A L S P T MT MG T V Q R 
A L S P T MT QG~JML A A 
Bovine heart E2 and protein X amino acid sequences were 
determined directly while the N-terminal human liver, E2(a), rat 
liver and yeast sequences were derived from the corresponding 
nucleotide sequences in the indicated publications. The primary 
structure of protein X is continuous with blank positions 
present only to optimise sequence alignment. For human and 
rat liver enzymes the corresponding internal repeat sequences, 
E2(b), at the start of the second lipoyl domain are included for 
comparison. Regions of complete or near complete sequence 
identity are boxed as shown. Amino acids given in parentheses 
have only been identified tentatively 
tein X exhibits lower homology (10 out of 22 
residues) with the equivalent N-terminal region 
from bovine heart E2. The N-terminal primary 
structures of human and bovine heart E2 are iden- 
tical over the first 22 amino acids. Heterogeneity 
was also observed at residue 13 in the protein X se- 
quence where both proline and glycine were found 
in comparable yields. During preparation of this 
manuscript, a similar, but not identical sequence, 
was published for the N-terminal region of protein 
X from bovine kidney [20]. Considerable s quence 
variability was noted amongst his group of en- 
zymes outwith the highly conserved regions as 
evidenced by alterations in sequence l ngth and the 
presence of many conservative and several non- 
conservative substitutions, notably in protein X 
which has several unique features e.g. two con- 
secutive glutamic acid residues at positions 16 and 
17. 
4. DISCUSSION 
4.1. Immunology of protein X and lipoate 
acetyltransferases (E2) 
In view of the striking homology (45o70 identity) 
in the N-terminal sequences of the bovine heart E2 
and X polypeptides, it may seem surprising that no 
immunological cross-reactivity is apparent 
employing antisera raised to the individual 
subunits. In one case, an anti-X serum has been 
reported to recognise the E2 enzyme also [4]. Con- 
flicting observations occur frequently with 
polyclonal sera where the characteristics of the IgG 
population depend on multiple factors, e.g. the 
method of antigen presentation, the immunisation 
regime and individual animal responses. 
Immunological studies have been widely used to 
demonstrate homologies within families of isoen- 
zymes where a linear relationship has been 
established between the degree of cross-reaction 
and the extent of sequence divergence. However, 
systematic analysis of a selection of purified 
lysozymes [21,22] revealed that enzymes exhibiting 
less than 60% homology did not usually show an 
immunological cross-reaction in precipitation 
assays or by microcomplement fixation. 
Antibodies to native proteins are primarily 
against non-contiguous epitopes (three-dimen- 
sional determinants) onthe surface of the polypep- 
tide while, for denatured antigen, linear elements 
of sequence (5-8 amino acids) are responsible for 
eliciting the major antibody response. If the com- 
mon sequences are highly conserved e.g. the 
PS/ALSPTM sequence in E2 and X they may be 
very weak immunogens ( ee [14]) accounting for 
the lack of cross-reaction between these two 
homologous proteins. The absence of cross- 
reaction may suggest that the E2 and X polypep- 
tides are encoded by separate genes rather than 
products arising from alternate xon splicing of a 
single genomic copy. In the latter case, the 
presence of long stretches of identical sequences in 
common exon segments should lead to im- 
munological cross-recognition by anti-E2 or anti-X 
sera. 
4.2. Organisation, origins and function of 
protein X 
Limited amino acid sequence data on bovine 
heart protein X indicate that this protein contains 
a lipoyl domain located at its N-terminus and 
belongs to a family of homologous enzymes, all 
the other members of which possess lipoate 
acetyltransferase activity. The heterogeneity at
position 13 in the protein X sequence where both 
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proline and glycine were present, probably 
represents eparate allelic forms of  the enzyme as 
the PDC was purified from a single beef heart. 
There are several reasons for suggesting that, in 
contrast o bovine E2, protein X contains only a 
single lipoyl domain:  (i) selective release of  lipoyl 
domains f rom E2 and X by limited proteolysis with 
a variety of  specific and non-specific proteases 
producing stable peptides, containing all the 
[14C]acetylation sites, in the 32-42 kDa range for 
E2 and 15-20 kDa range for protein X; (ii) the 
subunit molecular mass of  protein X, 51 kDa as 
opposed to 70 kDa for E2 is best accounted 'for by 
the absence of  an approx. 125 amino acid lipoyl 
domain from protein X. These domains are known 
to migrate anomalously on SDS-polyacrylamide 
gels owing to the presence of  Ala-Pro-r ich linker 
regions [11]; and (iii) specific cross-linking studies 
on E2 and X with phenylene-o-bismaleimide via 
substrate-generated hiols on lipoic acid groups has 
provided evidence for the presence of  two lipoyl 
groups per E2 chain and only a single lipoate on 
protein X [9]. 
Both E2 and protein X participate in the acetyla- 
t ion reactions o f  the complex [6] and apparently 
act as independent substrates for reductive acetyla- 
t ion by pyruvate dehydrogenase (El)  [23]. The in- 
ability to dissociate protein X f rom the E2 core 
assembly except under denaturing conditions also 
highlights the close physical and functional in- 
tegration of  these two components [3]. Indeed, 
protein X contains a C-terminal domain, 
equivalent o the intersubunit binding domain of  
E2, and may be an effective replacement for E2 
within the core structure. A recent report [20] also 
claims that protein X is involved in binding 
dihydrol ipoyl dehydrogenase (E3) and thus may 
also possess an E3 binding region which is highly 
conserved in both prokaryotic and eukaryotic 
PDCs  [8]. An intriguing question, therefore, cur- 
rently under investigation, relates to the precise 
role o f  component X: (i) is it an isoenzyme of  the 
major  lipoate acetyltransferase arising by gene 
duplication and independent evolution but with no 
distinctive biochemical function, or (ii) is it a 
variant of  E2 performing an essential structural or 
mechanistic role within the multimeric core 
assembly? Cloning and sequence analysis of  the 
protein X gene will be an important first step in 
endeavouring to answer these questions. 
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